Credit Suisse Group Analysts Give Reckitt Benckiser Group (RB) a GBX 5,800 Price Target

Share on StockTwits

Credit Suisse Group set a GBX 5,800 ($75.79) price objective on Reckitt Benckiser Group (LON:RB) in a report released on Tuesday morning. The brokerage currently has a sell rating on the stock.

RB has been the subject of several other reports. Deutsche Bank reaffirmed a buy rating on shares of Reckitt Benckiser Group in a report on Tuesday. Royal Bank of Canada set a GBX 5,100 ($66.64) price target on Reckitt Benckiser Group and gave the stock a sell rating in a report on Monday. UBS Group reaffirmed a neutral rating and set a GBX 6,400 ($83.63) price target on shares of Reckitt Benckiser Group in a report on Monday. JPMorgan Chase & Co. set a GBX 9,000 ($117.60) price target on Reckitt Benckiser Group and gave the stock a buy rating in a report on Monday. Finally, Jefferies Financial Group set a GBX 5,000 ($65.33) price target on Reckitt Benckiser Group and gave the stock a sell rating in a report on Monday. Three analysts have rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the stock. The company currently has an average rating of Hold and an average target price of GBX 6,974.38 ($91.13).

RB stock opened at GBX 5,969 ($78.00) on Tuesday. Reckitt Benckiser Group has a twelve month low of GBX 5,562 ($72.68) and a twelve month high of GBX 8,110.43 ($105.98).

The firm also recently disclosed a dividend, which will be paid on Thursday, May 23rd. Shareholders of record on Thursday, April 18th will be given a GBX 100.20 ($1.31) dividend. This is a boost from Reckitt Benckiser Group’s previous dividend of $70.50. The ex-dividend date is Thursday, April 18th. This represents a yield of 1.67%.

In other Reckitt Benckiser Group news, insider Elane Stock acquired 1,860 shares of the business’s stock in a transaction on Tuesday, February 19th. The stock was purchased at an average price of GBX 6,233 ($81.45) per share, for a total transaction of ¬£115,933.80 ($151,488.04).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.

Read More: How liquidity affects the bid-ask spread

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Kibo Energy  Stock Price Down 9.1%
Kibo Energy Stock Price Down 9.1%
Ecoreal Estate  Price Hits $0.12 on Major Exchanges
Ecoreal Estate Price Hits $0.12 on Major Exchanges
DAOstack  Trading Down 6.9% This Week
DAOstack Trading Down 6.9% This Week
Welltrado Reaches One Day Volume of $6,675.00
Welltrado Reaches One Day Volume of $6,675.00
Blue Capital Reinsurance  Upgraded to “Buy” by Zacks Investment Research
Blue Capital Reinsurance Upgraded to “Buy” by Zacks Investment Research
Direxion Daily MSCI India Bull 3x Shares  Announces $0.07 Quarterly Dividend
Direxion Daily MSCI India Bull 3x Shares Announces $0.07 Quarterly Dividend


Leave a Reply

 
© 2006-2019 Zolmax.